Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Tashimo

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The World Allergy Organization Journal|January 2, 2026
Differences in the efficacies of commonly used asthma questionnaires for predicting asthma-related outcomes among elderly and non-elderly patients in JapanKazufumi Takada, Maho Suzukawa, Hiroyuki Tashimo, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 19, 2026
Tezepelumab is effective in older patients with type 2 severe asthma, and baseline serum cytokine levels may be useful in predicting the efficacy of tezepelumabTaku Nishimura, Maho Suzukawa, Nobuharu Oshima, et al.
Internal Medicine (Tokyo, Japan)|July 28, 2020
A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to MepolizumabMaho Suzukawa, Nobuharu Ohshima, Hiroyuki Tashimo, et al.
Cellular Immunology|September 20, 2005
Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodelingNaomi Yamashita, Hiroyuki Tashimo, Hirofuni Ishida, et al.
Internal Medicine (Tokyo, Japan)|January 10, 2020
Patency Capsule AspirationKeita Takeda, Hiroyuki Tashimo, Kazuko Miyakawa, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 21, 2006
Involvement of GATA-3-dependent Th2 lymphocyte activation in airway hyperresponsivenessNaomi Yamashita, Hiroyuki Tashimo, Hirofumi Ishida, et al.
Cellular Immunology|February 11, 2003
Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF)Naomi Yamashita, Hiroyuki Tashimo, Hirobumi Ishida, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2023
Low Serum IL-18 Levels May Predict the Effectiveness of Dupilumab in Severe AsthmaShizuka Watanabe, Maho Suzukawa, Hiroyuki Tashimo, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2006
Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic modelNaomi Yamashita, Hiroyuki Tashimo, Yukiko Matsuo, et al.
The Journal of Experimental Medicine|October 14, 2009
Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptorSailaja Paruchuri, Hiroyuki Tashimo, Chunli Feng, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The World Allergy Organization Journal|January 2, 2026
Differences in the efficacies of commonly used asthma questionnaires for predicting asthma-related outcomes among elderly and non-elderly patients in JapanKazufumi Takada, Maho Suzukawa, Hiroyuki Tashimo, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 19, 2026
Tezepelumab is effective in older patients with type 2 severe asthma, and baseline serum cytokine levels may be useful in predicting the efficacy of tezepelumabTaku Nishimura, Maho Suzukawa, Nobuharu Oshima, et al.
Internal Medicine (Tokyo, Japan)|July 28, 2020
A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to MepolizumabMaho Suzukawa, Nobuharu Ohshima, Hiroyuki Tashimo, et al.
Cellular Immunology|September 20, 2005
Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodelingNaomi Yamashita, Hiroyuki Tashimo, Hirofuni Ishida, et al.
Internal Medicine (Tokyo, Japan)|January 10, 2020
Patency Capsule AspirationKeita Takeda, Hiroyuki Tashimo, Kazuko Miyakawa, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 21, 2006
Involvement of GATA-3-dependent Th2 lymphocyte activation in airway hyperresponsivenessNaomi Yamashita, Hiroyuki Tashimo, Hirofumi Ishida, et al.
Cellular Immunology|February 11, 2003
Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF)Naomi Yamashita, Hiroyuki Tashimo, Hirobumi Ishida, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2023
Low Serum IL-18 Levels May Predict the Effectiveness of Dupilumab in Severe AsthmaShizuka Watanabe, Maho Suzukawa, Hiroyuki Tashimo, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2006
Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic modelNaomi Yamashita, Hiroyuki Tashimo, Yukiko Matsuo, et al.
The Journal of Experimental Medicine|October 14, 2009
Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptorSailaja Paruchuri, Hiroyuki Tashimo, Chunli Feng, et al.
Pageof 3